The Editorial

by J. MEDDOW

[infinitetimes]

Stanford researchers cure Type 1 diabetes in mice with stem-cell and islet transplant breakthrough

STANFORD, Calif. — Researchers at Stanford Medicine have cured Type 1 diabetes in mice using a combination of blood stem-cell and pancreatic islet transplants, a development that could advance future treatments for the autoimmune disease.

The study, published Nov. 18, 2025 in the Journal of Clinical Investigation, found that transplanting donor blood stem cells alongside insulin-producing islet cells created a “hybrid” immune system that halted the body’s attack on its own pancreatic cells.

The treated mice no longer required insulin or immune-suppressing drugs during the six-month study period, and none developed graft-versus-host disease, a common complication in transplants.

“Our study … results in animals with a hybrid immune system,” senior author Dr. Seung K. Kim said, adding that similar steps are already used clinically for other conditions.

Independent reports confirm the approach both prevented diabetes in at-risk mice and reversed the disease in animals with established illness, with all treated subjects showing restored blood sugar control.

Type 1 diabetes occurs when the immune system destroys insulin-producing cells in the pancreas. Current treatment requires lifelong insulin therapy and, in transplant cases, long-term immunosuppression.

Researchers said the new method avoids those limitations by “re-educating” the immune system, though the findings remain limited to animal models.

Challenges to human use include sourcing sufficient donor islet cells and confirming safety and effectiveness in clinical trials.

Still, scientists say the approach could represent a major step toward a functional cure and may have broader applications for autoimmune diseases and organ transplantation.

Sources

Stanford Medicine

ScienceAlert

[infinitetimes]

Matt Gaetz claims he was briefed on a secret alien breeding program while in office

WASHINGTON — Former U.S. Rep. Matt Gaetz said he was once briefed by a member of the military about an alleged secret program involving alien-human hybrids.

Speaking on a The Benny Show podcast interview, Gaetz, who served in Congress from 2017 to 2024, said a uniformed U.S. Army service member told him that humans and extraterrestrial beings were part of a breeding program designed to enable communication with other worlds.

“I had someone come and brief me, who was in a military uniform, worked for the United States Army, that was briefing me on the locations of hybrid breeding programs where captured aliens were breeding with humans to create some hybrid race that could engage in intergalactic communication,” Gaetz said. “An actual uniformed member of the United States Army briefed me on that.”

He said the briefing took place in a non-classified setting at his congressional office in Florida and that members of his staff were present.

Gaetz further claimed the alleged program involved humans abducted from war zones and migrant caravans and operated across multiple facilities, though he did not provide evidence or specific locations.

No U.S. government agency has confirmed the existence of such a program, and no supporting documentation has been made public.

Sources

The Independent (UK)

HuffPost

[infinitetimes]

Cancer scientists, for the first time, discover genetic clues as to what drives tumor growth

LONDON — Scientists in the United Kingdom have identified the full range of genetic mutations that drive tumor growth, a breakthrough that could reshape cancer treatment and advance precision medicine.

Researchers from The University of Manchester and The Institute of Cancer Research, London mapped the mutations that cause cells to become cancerous, marking the first time scientists have fully decoded these genetic changes, according to a study published in Nature Genetics.

Cancer develops when DNA mutations disrupt normal cell growth. While many mutations are harmless, some — known as “driver mutations” — fuel tumor development. Until now, scientists had only a partial understanding of how these mutations interact.

The researchers used advanced genomic analysis to identify patterns across different cancer types, allowing them to distinguish key driver mutations from less significant ones.

Professor Richard Houlston, head of cancer genomics at The Institute of Cancer Research, London, said: "This study provides one of the clearest demonstrations yet that reading the full genetic history of a tumor can unlock clues to better patient care. The future of cancer treatment lies not just in finding mutations, but in understanding the story they tell.”

The findings could help doctors better match patients with targeted therapies, improving outcomes and reducing ineffective treatments.

Experts say the discovery could accelerate the development of new drugs and improve existing therapies by targeting the specific mutations responsible for a patient’s cancer.

Cancer remains one of the leading causes of death worldwide, accounting for nearly ten million deaths each year, according to global health data.

The researchers said further work is needed to translate the findings into clinical treatments, but they called the study a major step toward more personalized cancer care.

Sources

Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types is published in  Nature Genetics

The University of Manchester

The Institute of Cancer Research, London

[infinitetimes]

Study Finds Living Organisms Emit Faint Light That Disappears at Death

Researchers have found that living organisms emit an extremely faint light that appears to vanish upon death, according to a recent experimental study.

The research, conducted by scientists from the University of Calgary and the National Research Council of Canada, observed what is known as ultraweak photon emission (UPE)—a subtle release of light particles from biological systems.

Using highly sensitive EMCCD cameras in pitch-black conditions, scientists observed that living mice emitted significantly more light than their deceased counterparts, even when body temperatures were identical. 

What Are "Biophotons"?

The light observed in the study consists of biophotons, which are tiny particles of visible light produced during metabolic processes in cells. These emissions are linked to chemical reactions involving reactive oxygen species—molecules generated as cells produce energy and respond to stress.

Although often described as a "glow," the light is far too faint to be seen by the human eye. Previous research has suggested that this biological luminescence exists continuously in living organisms but remains undetectable without specialized instruments.

Not an Aura—A Biological Process

Scientists caution that the findings should not be confused with supernatural or paranormal interpretations. While the idea of a "light leaving the body" may sound mystical, the phenomenon is grounded in measurable biochemical activity.

The disappearance of these emissions after death reflects the cessation of metabolic processes, particularly those involving oxidation reactions within cells.

Potential Applications

Researchers say the discovery could have practical applications in medicine and agriculture. Monitoring ultraweak photon emissions may offer a non-invasive way to assess cellular health, stress, or injury in real time.

This could eventually lead to new diagnostic tools capable of detecting disease or tissue damage without the need for invasive procedures.

Sources:

• The Journal of Physical Chemistry Letters (2025)

• University of Calgary & National Research Council study